Human Antibodies: Antibody drug conjugates: Progress, pitfalls, and promises

Nascent Biotech founder Dr. Mark C. Glassy has co-authored a new paper appearing in Human Antibodies entitled, “Antibody drug conjugates: Progress, pitfalls,
and promises.”

Please click here to read a PDF version of the article.